Answers are grounded in this paper and cite their sources.
This research aims to estimate and forecast the economic cost of diabetes in Pakistan. The study used Pakistan Social and Living Standards Measurement Survey (PSLM) 2018-19 datasets and employed multiple supervised learning estimation methods to achieve reliable and efficient estimates for policy analysis. Furthermore, the Global Burden of Diseases (GBD) data is used to forecast diabetes patients and economic costs till 2030 using the automatic Autoregressive Integrated Moving Average (ARIMA) model. Empirically, the average monthly direct cost incurred by an individual for diabetes management is 5,591 PKR (67,092 PKR annually), which is about 19% of total income, and these expenditures vary from 9% to 33% based on bootstrapped confidence intervals. It is forecasted that the number of diabetes patients will increase from 2.17 million to 2.79 million from 2021 to 2030, at an average growth rate of 2.84%. Furthermore, the total cost is expected to increase from 320.21 billion to 411.17 billion rupees from 2021 to 2030, at an average growth rate of 2.78%. The research findings suggest that a targeted fiscal policy aimed toward subsidies and awareness would be effective to overcome productivity loss and to ensure a healthy and active labor force in the future.
No takes yet. Share an insight, caveat, or question.
Mahmood et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: